Vitamin C during pregnancy supports early brain development, OHSU study finds
Findings underscore importance of nutrition for both healthy pregnancy, early childhood development; OHSU expanding prenatal nutrition counseling, access to healthy foods.
Research
More Research Stories
- Latest Stories
Gene mutations cause leukemia, but which ones?
February 21, 2017
Research published today in the journal Oncotarget, sought to better understand one “typo” in a standard leukemia assay, or test. While studying cancer biology and completing his doctorate at the OHSU Knight Cancer Institute, Kevin Watanabe-Smith, Ph.D., encountered a new problem: an issue with the model system itself.
Exercise during pregnancy decreases costs, improves outcomes in obese women: study
February 15, 2017
Between morning sickness and lack of sleep, it may be the last thing pregnant women want to do, but research conducted at OHSU shows exercise in pregnancy pays off.
Mole Mapper app ‘crowd-sources’ photos for skin cancer research, prevention
February 14, 2017
Research team shares initial data with scientific community.
Medicare spent more than $650 million in two years on a drug prescribed by less than 1 percent of physicians: study
February 13, 2017
U.S. taxpayers spent more than $650 million in 2013 and 2014 on one medication with questionable usefulness prescribed by less than 1 percent of clinicians, according to new research by scientists with OHSU and the OHSU/Oregon State University School of Pharmacy in Portland.
Fluoride tablets inadequate alternative to water fluoridation, study finds
February 02, 2017
A first-of-its-kind study, published in Academic Pediatrics, finds fluoride tablets may not be an effective alternative to water fluoridation.
New genome-mapping technique opens new avenues for precision medicine
January 30, 2017
OHSU scientists have uncovered a method for quickly and efficiently mapping the genome of single cells within the body. Their findings, published Jan. 30 in the journal Nature Methods, clears the way for a significant advance in precision medicine, including cancer and many other disease areas.
Vaccine technology developed by OHSU scientists acquired by industry leaders
January 25, 2017
A first-of-its-kind vaccine technology platform developed by renowned scientists at OHSU in Portland, Oregon, has been acquired by Vir Biotechnology, a San Francisco-based biotech startup backed by leading industry investor ARCH Venture Partners and the Bill & Melinda Gates Foundation, a leading funder of global health initiatives.
Low-dose aspirin may slow growth of colon, pancreatic cancer cells
January 19, 2017
An OHSU and Oregon State University study finds aspirin may slow the spread of some types of colon and pancreatic cancer cells, Their findings are published in the American Journal of Physiology—Cell Physiology.
Should cancer doctors disclose financial conflicts of interest when they tweet?
January 17, 2017
Conversations centered on health care are increasingly taking place on social media. For example, doctors, patients, advocates, the FDA and members of the pharmaceutical industry frequently interact on Twitter, discussing new drugs and devices.
Scientists reveal non-addictive pathway to pain relief
January 12, 2017
OHSU research suggests an avenue for developing treatments for chronic pain that harness the medicinal properties of cannabis while minimizing the threat of addiction.